The Pharmacy Benefit Brief | January 2022

Welcome to the Pharmacy Benefit Brief. This brief is your monthly snapshot of news from America’s prescription drug supply chain including pharmacy benefit managers, independent pharmacies, and drug manufacturers. WISCONSIN EMPLOYERS ON WHITE BAGGING… Recently, we introduced you to the drug delivery practice known as “white bagging.” To reacquaint you with it, here’s a refresher:...

Keep Reading

New Report: Anti-Competitive Practices Lead to High Prescription Drug Costs

(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today released a new report, “Drug Manufacturer Strategies for Keeping Drug Costs High,” on pharmaceutical industry pricing tactics that increase prescription drug costs for patients. The report, conducted by the research firm Visante, examines certain drug manufacturer anti-competitive tactics that affect many different types of prescription drugs. For...

Keep Reading

PCMA Statement on House Judiciary Committee Vote on Drug Pricing Legislation

(Washington, D.C.) — Pharmaceutical Care Management Association President and CEO JC Scott issued the following statement on the House Judiciary Committee’s markup of H.R. 2883, the “Stop Stalling Access to Affordable Medications”; H.R. 2891, the “Preserve Access to Affordable Generics and Biosimilars Act”; H.R. 2873, the “Affordable Prescriptions for Patients Through Promoting Competition Act of...

Keep Reading

The Medicare Prescription Drug Rebate Rule

Keep Reading

Promotion of Higher-Cost Drugs

There is no excerpt because this is a protected post.

Keep Reading

Extending Market Exclusivity Periods

There is no excerpt because this is a protected post.

Keep Reading

Patent Abuses Delay Competition

There is no excerpt because this is a protected post.

Keep Reading

Drug Manufacturer Strategies for Keeping Drug Costs High

There is no excerpt because this is a protected post.

Keep Reading

PCMA Statement on the Biden Administration’s Drug Pricing Plan

(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the Biden administration’s plan for high drug prices: “While we review the recently released Comprehensive Plan for Addressing High Drug Prices report, America’s pharmacy benefit managers, PBMs, applaud the Administration for its focus on reducing prescription drug...

Keep Reading

PCMA: Medicare Trustees’ Report Highlights Urgency to Permanently Repeal Rebate Rule

(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the “2021 Annual Report of the Boards of Trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds:” “The 2021 edition of the Medicare Trustees’ report highlights that negotiations between pharmacy benefit managers, PBMs,...

Keep Reading